SAS GENE FUNCTIONS AND CHROMATIN AND SILENCING

SAS 基因功能以及染色质和沉默

基本信息

  • 批准号:
    6180923
  • 负责人:
  • 金额:
    $ 20.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-08-01 至 2002-07-31
  • 项目状态:
    已结题

项目摘要

The proposed project's goals are to understand the function of the newly identified SAS gene family in chromatin-mediated transcriptional regulation and genomic silencing. A sequence signature shared by Sas proteins and enzymes known to have acetyltransferase activity suggests that the Sas proteins function by acetylating key chromatin components. SAS genes were discovered in the yeast Saccharomyces, but sequence homologs including human MOZ and Tip60, have significant implications for human health. MOZ is the common 5' partner in recurrent 8p11 translocations that lead to the M4/M5 subtype of acute myeloid leukemia. Tip60 is a human gene associated with HIV-Tat that facilitates increased levels of Tat-dependent transcription. Understanding the most conserved elements of SAS function may thus lead to increased understanding of leukemia and HIV related disease including AIDS and AIDS-related malignancies. Analysis of yeast SAS function revealed that SAS2 or SAS3 mutants are defective in transcriptional silencing. The third yeast gene, ESA1, is essential for viability. Because ESA1 is most closely related to the human homologs, much of the proposal focuses on its analysis. Conditional alleles, including mutations in the putative acetyltransferase domain, will identify critical regions of ESA 1. Analysis of conditional alleles will facilitate the proposed genetic and cell biological dissection of ESA 1. It will be determined if ESA 1 is required at a single or multiple points in the cell cycle and if loss of ESA1 function leads to silencing defects, thereby potentially identifying genetic loci whose repression is essential for normal mitotic growth. Biochemical characterization will test directly the hypothesis that SAS genes function through chromatin acetylation. Identification of relevant substrates and regulators of activity will be sought through biochemical and genetic approaches. Tests to determine limits of functional conservation between yeast and human SAS genes will be performed by determining if human genes can suppress yeast mutant phenotypes. Experiments will be performed to test the hypothesis that mis-localization of SAS activity may lead to disease by altering locally defined patterns of transcriptional regulation. Results from these diverse experimental approaches should establish mechanisms of SAS gene function and suggest how disruption of this function leads to alterations in genomic silencing and activation.
拟议项目的目标是了解 染色质介导转录中新发现的SAS基因家族 调控和基因组沉默。由SA共享的序列签名 已知具有乙酰转移酶活性的蛋白质和酶表明 SAS蛋白通过乙酰化关键的染色质成分发挥作用。 在酵母菌中发现了SAS基因,但序列 包括人类MoZ和Tip60在内的同源物具有重大意义 为了人类健康。MOZ是复发性8p11中常见的5‘伴侣 导致M4/M5亚型急性髓系白血病的易位 白血病。Tip60是一种与HIV-TAT相关的人类基因 促进依赖于TAT的转录水平的提高。 因此,了解SAS功能中最保守的元素可能会导致 增加对白血病和艾滋病毒相关疾病的认识 包括艾滋病和艾滋病相关的恶性肿瘤。酵母菌SAS的分析 功能显示SAS2或SAS3突变体在 转录沉默。第三种酵母菌基因esa1是 生存能力。因为ESA1与人类同源物关系最密切, 该提案的大部分内容都集中在其分析上。条件等位基因, 包括假定的乙酰转移酶区域的突变,将 确定ESA的关键区1.条件等位基因分析 将促进拟议的遗传和细胞生物学解剖 ESA 1。将确定是否需要在单个或 细胞周期中的多个点,如果ESA1功能的丧失导致 到沉默缺陷,从而潜在地识别遗传基因座 它的抑制对于正常的有丝分裂生长是必不可少的。生化 表征将直接检验SAS基因的假设 通过染色质乙酰化起作用。相关人员的识别 将通过寻找活动的底物和调节器 生物化学和遗传方法。确定限值的测试 酵母和人类SAS基因之间的功能保守将是 通过确定人类基因是否可以抑制酵母突变来实现 表型。我们将进行实验来检验这一假设 SAS活性的错误定位可能通过改变导致疾病 转录调控的局部定义模式。结果来自 这些不同的实验方法应该建立起 SAS基因的功能,并提示该功能的中断如何导致 基因组沉默和激活的变化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LORRAINE PILLUS其他文献

LORRAINE PILLUS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LORRAINE PILLUS', 18)}}的其他基金

Chromatin Regulation by Deacetylation and SUMO-Targeted Ubiquitin Ligation
通过脱乙酰化和 SUMO 靶向泛素连接调节染色质
  • 批准号:
    7883402
  • 财政年份:
    2009
  • 资助金额:
    $ 20.46万
  • 项目类别:
Chromatin Regulation by Deacetylation and SUMO-Targeted Ubiquitin Ligation
通过脱乙酰化和 SUMO 靶向泛素连接调节染色质
  • 批准号:
    8293151
  • 财政年份:
    2009
  • 资助金额:
    $ 20.46万
  • 项目类别:
Chromatin Regulation by Deacetylation and SUMO-Targeted Ubiquitin Ligation
通过脱乙酰化和 SUMO 靶向泛素连接调节染色质
  • 批准号:
    8089534
  • 财政年份:
    2009
  • 资助金额:
    $ 20.46万
  • 项目类别:
Chromatin Regulation by Deacetylation and SUMO-Targeted Ubiquitin Ligation
通过脱乙酰化和 SUMO 靶向泛素连接调节染色质
  • 批准号:
    8319735
  • 财政年份:
    2009
  • 资助金额:
    $ 20.46万
  • 项目类别:
FUNCTIONAL ANALYSIS OF THE SIR2 SILENCING PROTEIN
SIR2 沉默蛋白的功能分析
  • 批准号:
    6180819
  • 财政年份:
    1997
  • 资助金额:
    $ 20.46万
  • 项目类别:
FUNCTIONAL ANALYSIS OF THE SIR2 SILENCING PROTEIN
SIR2 沉默蛋白的功能分析
  • 批准号:
    2869889
  • 财政年份:
    1997
  • 资助金额:
    $ 20.46万
  • 项目类别:
Analysis of MYST Family Acetyltransferase Functions
MYST家族乙酰转移酶功能分析
  • 批准号:
    7116698
  • 财政年份:
    1997
  • 资助金额:
    $ 20.46万
  • 项目类别:
Analysis of MYST Family Acetyltransferase Functions
MYST家族乙酰转移酶功能分析
  • 批准号:
    7090639
  • 财政年份:
    1997
  • 资助金额:
    $ 20.46万
  • 项目类别:
SAS GENE FUNCTIONS AND CHROMATIN AND SILENCING
SAS 基因功能以及染色质和沉默
  • 批准号:
    6386755
  • 财政年份:
    1997
  • 资助金额:
    $ 20.46万
  • 项目类别:
Functional Analysis of the SIR2/HST Deacetylases
SIR2/HST 脱乙酰酶的功能分析
  • 批准号:
    6578462
  • 财政年份:
    1997
  • 资助金额:
    $ 20.46万
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    $ 20.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了